{
    "code": "02021720",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02021720",
    "time": "2021-01-22 04:54:01",
    "許可證字號": "衛署藥輸字第021720號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/04\/20",
    "發證日期": "107\/12\/24",
    "許可證種類": "製　劑",
    "舊證字號": "02020406",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202172005",
    "中文品名": "弗洛瑞斯注射液",
    "英文品名": "FLUOROURACIL INJECTION",
    "適應症": "大腸癌、乳癌、結腸癌。",
    "劑型": "270注射劑",
    "包裝": "10、20、100毫升小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "FLUOROURACIL",
    "限制項目": "02輸　入 1Q不得輸入",
    "申請商名稱": "1504401100  輝瑞大藥廠股份有限公司",
    "申請商地址": "台北市信義區松仁路100號42、43樓",
    "主製造廠": [
        {
            "製造廠名稱": "FAU0034000  PFIZER (PERTH) PTY LIMITED",
            "製造廠廠址": "15 BRODIE HALL DRIVE TECHNOLOGY PARK, BENTLEY WESTERN AUSTRALIA 6102",
            "製造廠公司地址": "",
            "製造廠國別": "AUSTRALIA",
            "製程": ""
        }
    ],
    "CCC號列": "30049071005 抗癌藥Anti-cancer preparations",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1008400200",
            "成分名稱": "FLUOROURACIL",
            "含量描述": "25",
            "含量": "25.0000000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "Fluorouracil 藥輸021720-103-02-21.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021720&Seq=001&Type=9"
        },
        {
            "title": "Fluorouracil_外盒包裝核定本-104-09-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02021720&Seq=001&Type=8"
        }
    ]
}